课题基金 / 基金详情

A National Resource for Lung disease-specific iPS cells

A National Resource for Lung disease-specific iPS cells
肺病特异性 iPS 细胞的国家资源
批准号:
8913259
负责人:
Darrell N. Kotton
金额:
$53.32万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-15 至 2019-04-30

项目摘要

项目成果

Darrell N. Kotton的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This proposal seeks to estabalish a formalized national resource for lung researchers consisting of a lung disease-specific induced pluripotent stem cell (iPSC) bank that can be shared without restriction or exclusivity. More than 200 human lung disease-relevant iPSC clones, and their gene-edited progeny, are now banked in the Center for Regenerative Medicine (CReM) of Boston University/Boston Medical Center, providing an unprecedented opportunity for any basic scientist to derive an inexhaustible supply of patient-derived lung epithelial, vascular, immune, or interstitial cells. These cells containing each patient's own genetic background are now available for in vitro human lung disease modeling, drug screening of personalized therapeutics, and the development of future lung regeneration cell-based therapies. The most valuable human clones in this bank not only carry the most common lung disease-inducing mutations (e.g. mutations in loci encoding CFTR, Alpha-1 antitrypsin, BMPR2, SPC, SPB, ABCA3, and NKX2.1), but also carry knock-in fluorochrome reporters targeted to specific loci through state-of-the-art gene editing technologies. In parallel, the bank also includes 50 mouse iPSC clones generated from transgenic or knock-in mice that carry well characterized fluorochrome reporters of lung lineages (SPC-GFP, T1a-GFP, Tie2-GFP, SMA-GFP, and Nkx2.1-GFP). We propose to establish this cell bank through four specific aims to accomplish the goals of: a) national sharing of iPSCs that comprise a critical resource in high demand by both basic and clinical lung researchers, b) establishment of quality assurance approaches and methods for banking an exhaustive panel of human and mouse lines carrying the most common gene mutations and lung lineage reporter genes required by the majority of U.S. lung researchers in the years ahead, c) development of a formalized education and training program able to nationally disseminate the expertise required to fully harness these new tools and differentiate them into lung lineages, and d) self-sustained maintenance of the bank financially, logistically, and educationally.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing a patient-specific organoid model of pulmonary fibrosis using iPSCs
  • 批准号:
    10026360
  • 项目类别:
  • 资助金额:
    $50.86万
  • 财政年份:
    2020
  • 负责人:
    Darrell N. Kotton
  • 依托单位:
Developing a patient-specific organoid model of pulmonary fibrosis using iPSCs
  • 批准号:
    10318560
  • 项目类别:
  • 资助金额:
    $67.57万
  • 财政年份:
    2020
  • 负责人:
    Darrell N. Kotton
  • 依托单位:
Developing a patient-specific organoid model of pulmonary fibrosis using iPSCs
  • 批准号:
    10525231
  • 项目类别:
  • 资助金额:
    $65.39万
  • 财政年份:
    2020
  • 负责人:
    Darrell N. Kotton
  • 依托单位:
Editing Alveolar Progenitor Cells for Correction of Monogenic Disease
  • 批准号:
    10198995
  • 项目类别:
  • 资助金额:
    $125.83万
  • 财政年份:
    2016
  • 负责人:
    Darrell N. Kotton
  • 依托单位:
海外基金